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Crosslinkinga b s t r a c t
Accurate evaluation of the biological performance of biomaterials requires the correct assessment of their
native-like cell ligation properties. However, cell attachment studies often overlook the details of the
substrate-cell binding mechanisms, be they integrin-mediated or non-specific, and ignore the class-
and species-specificities of the cell adhesion receptor involved. In this work we have used different col-
lagen (Col) substrates (fibrillar collagens I, II and III and network-forming Col IV), containing different
affinity cell-recognition motifs, to establish the influence of the receptor identity and species-
specificity on collagen-cell interactive properties. Receptor expression was varied by using cells of differ-
ent origin, or transfecting collagen-binding integrins into integrin-null cells. These include mouse C2C12
myoblasts transfected with human a1, a2, a10 or a11; human fibrosarcoma HT1080 cells which consti-
tutively express only human a2b1, and rat glioma Rugli cells, with only rat a1b1. Using these lines, the
nature of integrin binding sites was studied in order to delineate the bioactivity of different collagen sub-
strates. Integrin ligation was studied on collagen coatings alongside synthetic (GFOGER/GLOGEN) and
Toolkit (Col II-28/Col III-7) triple-helical peptides to evaluate (1) their affinity towards different integrins
and (2) to confirm the activity of the inserted integrin in the transfected cells. Thin films of dermal and
tendon Col I were used to evaluate the influence of the carbodiimide (EDC)-based treatment on the cel-
lular response on Col of different origin. The results showed that the binding properties of transfected
C2C12 cells to collagens depend on the identity of inserted integrin. Similar ligation characteristics were
observed using a1+ and a10+ cells, but these were distinct from the similar binding features of a2+ and
a11+ cells. Recombinant human and rat-a1 I domain binding to collagens and peptides correlated with
the cell adhesion results, showing receptor class- and species-specificities. The understanding of the
physiologically relevant cell anchorage characteristics of bio-constructs may assist in the selection of
(1) the optimum collagen source for cellular supports and (2) the correct cellular model for their biolog-
ical assessment. This, in turn, may allow reliable prediction of the biological performance of bio-scaffolds
in vivo for specific TE applications.
Statement of Significance
Integrins play a vital role in cellular responses to environmental cues during early-stage cell-substrate
interaction. We describe physiologically relevant cell anchorage to collagen substrates that present dif-
ferent affinity cell-recognition motifs, to provide experimental tools to assist in understanding integrin
binding. Using different cell types and recombinant integrin a1-I-domains, we found that cellular
response was highly dependent on collagen type, origin and EDC-crosslinking status, as well as on the
integrin class and species of origin. This comprehensive study establishes selectivity amongst the four
collagen-binding integrins and species-specific properties that together may influence choice of cell type
and receptor in different experimental settings. This work offers key guidance in selecting of the correct
cellular model for the biological testing of collagen-based biomaterials.
 2017 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Natural extracellular matrix (ECM) contains a mixture of pro-
teins and polysaccharides that display biochemical cues which
influence cell behaviour. This composition determines the cell-
binding affinity through specific interaction with integrins pre-
sented on the cell surface [1,2]. ECM components possess different
adhesive motifs with diverse affinities towards a variety of cell
recognition receptors. Despite this complex tissue composition,
for many years, collagen (in forms including gels, scaffolds and
membranes) has been a commonly used biomaterial due to its bio-
compatibility, biodegradability and low immunogenicity, together
with its ability to form fibres with high tensile strength [2–5]. Col-
lagen (Col), being the principal structural protein in all vertebrates,
comprises a family of genetically distinct molecules with a com-
mon triple helix configuration of three polypeptide subunits
known as a-chains [4,6]. These triple helices comprise a molecule
of tropocollagen, the basic building block of collagen fibres.
Tropocollagen molecules associate in a staggered fashion to pro-
duce collagen fibrils, which are strengthened and stabilized mainly
by enzymatic and non-enzymatically catalysed covalent
cross-links. The extent of these crosslinks is age-dependent and
tissue-specific. The human genome contains 28 collagens and the
corresponding proteins are made up of about 40 gene products,
identified and described in varying detail [6]. Variations in collagen
types are due to differences in the primary sequence and assembly
of the polypeptide subunits, the lengths of the helix and the inter-
ruptions and terminations of the collagenous helical domains. The
best known and the most abundant collagens are fibrillar collagens
I, II and III, each containing different affinity cell-recognition motifs
that support cellular activity mainly through their interaction with
cell-associated integrins a1b1, a2b1, a10b1 and a11b1 [6,7]. Col I
is a major ECM component and accomplishes both structural and
cell adhesive roles in many vital organs and tissues [3,8]. Col II is
the chief element in articular cartilage (approximately 60% of the
dry weight of this tissue) [2,9] while Col III is an important compo-
nent of reticular fibres, where it is commonly found alongside Col I
[10], for example in skin and blood vessel walls. These collagens
have been used, alone or in combination, for the design of bio scaf-
folds [2,3,5]. Col I is the most widely-explored option, owing to its
physical and biological attributes, the ability to isolate it to high
purity and its reasonable cost. Despite this, the addition of otherFig. 1. The crystal structures of integrin-a2 I domain and its Mg2+-dependent binding to
a2b1 integrin with inserted I domain in the a subunit. Adapted from [13]collagens may be highly beneficial. For example, the introduction
of Col III seems advantageous when engineering cellular supports
for cardiac tissue replacement as this collagen, in native tissue,
plays an important role by linking contractile elements of adjacent
myocytes [10]. The structural diversity observed in different Col
types affects their adhesive motifs which may in turn have impact
on their cell-substrate interactions via integrins [6,7].
Integrins are transmembrane glycoproteins that represent a
family of 24 heterodimeric signalling receptors each composed of
a single a- and b-subunit. These play a central role in mediating
dynamic cell–cell and cell–extracellular matrix/substrate interac-
tions. Integrins recognise a large number of similar motifs pre-
sented in the different types of collagens. They are unique,
among adhesion molecules, as their adhesiveness is dynamically
regulated through ‘‘inside-out signalling,” which in turn leads to
ligand binding and signal transduction in the classical ‘‘outside-
in” direction [11–14]. The strength of cellular adhesiveness of an
integrin is largely governed by the intrinsic affinity of the individ-
ual receptor–ligand interface, which is dynamically modulated by
conformational changes. Of the four collagen-binding integrins,
a1b1 and a2b1 have been studied for almost three decades whilst
the properties of both a10b1 and a11b1 are still not fully explored
[7].
All collagen-binding integrins are distinguished by the pres-
ence, within the a-subunit, of an inserted A-domain, termed
an I domain. The I domain co-ordinates a divalent cation,
Mg2+, in its metal ion dependent adhesion site, which is the
principal site of interaction with collagens [7,13,15]. The crystal
structure of integrin a2 I domain when interacting with Col
triple-helical GFOGER motif has been resolved [15]. Fig. 1
schematically represents the position of this I domain in the
a-subunit of a2b1 integrin and illustrates the complex forma-
tion between a collagen triple helical motif (GFOGER) and an
integrin I domain via coordination with Mg2+. The mechanism
of this interaction dictates that the carboxylate sidechain of
the glutamic acid (E) residues in GxOGEx’ and the presence in
the culture medium of the divalent cation (Mg2+) are critical
for integrin-mediated binding. The removal of Mg2+ cations by
chelation with ethylenediaminetetraacetic acid, EDTA, effectively
blocks this mode of interaction and is frequently used as a con-
venient method to deconvolute this native-like adhesion from
non-integrin-based cell attachment [16,17].GFOGER collagen motif was produced from pdb:1DZI. Schematic representation of
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domains within the a-subunit, recombinant I domains offer the
possibility to test for direct integrin-collagen engagement in a
cell-free system, that is without interference/input of other cell-
surface receptors and independently on the receptor density on
the cell surface. As such this analysis can shed light on possible
class-and species-specificities of integrin-substrate interactions.
Only the correct stimulation of cell-attachment mechanisms,
through an intimate, biologically relevant cell-substrate ligation,
leads to the further cell activity such as spreading and prolifera-
tion. Despite this, many cell attachment studies overlook the detail
of the binding mechanisms, be they integrin-mediated or non-
specific. Moreover, the class-and species-specificities of the cell
adhesion receptor involved in the direct substrate-integrin associ-
ation are frequently ignored. In this study, the binding abilities of
all four of the collagen-specific integrins have been probed by
means of cells with diverse species-specificity (murine, human
and rat) and which express different collagen-binding receptors:
(1) C2C12 mouse myoblasts stably transfected with human a1+,
a2+, a10+ or a11+ b1 integrins; (2) HT1080 human fibrosarcoma,
expressing human a2b1, and (3) Rugli cells derived from a rat
glioma that express rat a1b1. The original C2C12, non-
transfected mother cells, which do not express collagen-binding
receptors, were used as a negative control. For this study, adhesion
assays were carried out on monolayer coatings thereby removing
any possible impact of the substrate physical material properties
[18].
To verify the activity of the transfected cells, studies of collagen-
binding were carried out alongside investigation of binding to syn-
thetic peptides containing cell-affinity motifs GFOGER and GLO-
GEN, and on their Toolkit equivalents II-28 and III-7, respectively,
which were obtained from libraries of overlapping triple-helical
peptides. Both Toolkit samples are composed of an active guest
sequence, encompassing the natural sequence of collagens II and
III (Toolkit-II and III respectively) [7,19–23]. A triple-helical pep-
tide containing the sequence GFOGER (present in Col I, Col II and
Col IV) is the highest affinity ligand for integrin a2b1, whilst GLO-
GEN (an important ligand in Col III) is the best cell-recognition
motif for integrin a1b1. The Toolkit peptides II-28 and III-7 specif-
ically possess GFOGER and GLOGEN motifs, respectively, in their
29-residue section of primary collagen sequence, and as such, were
selected for cell attachment tests, taking into account that screen-
ing of Toolkit II and III on collagen-binding integrins has previously
been effectively used in our lab for the identification of cell-
binding sites within collagen [7,23].
The influence of Col I source on its cell adhesive properties was
studied on both monolayers and 2D films produced from insoluble
bovine dermal and tendon-derived samples. Thin films were cross-
linked (XL) with different dose of EDC (1-ethyl-3-(3-dimethylami
nopropyl-carbodiimide hydrochloride) in the presence of NHS (N-
hydroxy-succinimide), to evaluate the influence of the treatment
conditions on the cellular response of different collagen substrates.
Carbodiimide-based crosslinking constitutes one of the most suc-
cessful chemical methods to modulate the mechanical stability
and the dissolution resistance of collagenous materials. It is highly
efficient, nontoxic, and by-products can be easily eluted [17,24–
28]. However, this procedure results in the consumption of car-
boxylate sidechains on glutamate (E) or aspartate (D) residues
through their reactions with an adjacent lysine (K) e-amino group
[24,29,30]. Both glutamate and aspartate are important amino acid
components of numerous cell-recognition ligands in collagen
molecules and their depletion, as shown in [7,17,31,32], may lead
to the loss of integrin-substrate ligation.
Understanding the effect of the source and the type of collagen,
before and after crosslinking treatment, on the biological behavior
of collagenous materials may assist in the selection of the optimumcomponents for the design of specific ECM-like devices to more
closely match the properties of the tissues they aim to repair or
replace. This study used cell lines that express single collagen-
binding integrins as a tool to probe collagen ligation properties.
The results show the importance of the receptor class- and
species-specificities for cell-substrate interaction. Moreover, the
work highlights the differential cell-recognition of different colla-
gen types which is modified with ranging crosslinking densities
and the importance of selecting the correct cellular model to assess
the biological properties of protein-based biomaterials.2. Materials and method
2.1. Materials
2.1.1. Cell lines
HT1080 (fibroblasts from human sarcoma) cells were obtained
from the European Collection of Animal Cell Cultures, Porton
Down, UK. The parent C2C12 mouse myoblast cells and C2C12
cells, stably transfected with the human integrin a1, a2 and a11
subunits, were produced as described in [33]. The C2C12 cells sta-
bly transfected with integrin a10 were a kind gift from Dr. E
Lungren-Akerland, Xintela AB, Lund, Sweden. Rugli (derived from
a rat glioma) cells were a kind gift from Dr. J. Gavrilovic, University
of East Anglia, Norwich, UK.
The human I domains from T141 to E335 for a1 and from S141
to E336 for a2 were expressed as recombinant N-terminal GST
fusion proteins as detailed in [20,34]. In the same way, rat a1 I
domain has been cloned from Rugli cells fused to GST, started from
S226 to E421.
2.1.2. Materials
Insoluble microfibrillar collagens type I derived (1) from bovine
Achilles tendon, termed Col I(S), was purchased from Sigma–
Aldrich Co. Ltd. UK, and (2) from bovine epidermis layer in skin,
termed Col I(D), was purchased from Devro Medical Bathurst,
NSW, Australia. Soluble fibrillar collagens type II (Col II), from
bovine tracheal cartilage, type III (Col III), from human placenta,
and network soluble Col IV, also extracted from human placenta,
were all purchased from Sigma-Aldrich Co. Ltd. UK. 9-
Fluorenylmethoxycarbonyl (Fmoc) protected amino acids and N,
N-Dimethylformamide (DMF), used for peptide synthesis, were
supplied by AGTC Bioproducts (Hessle, UK). All other amino acids
and reagents were purchased from Sigma-Aldrich (Gillingham,
UK). Acetic acid (2 M), 1-ethyl-3-(3-dimethylaminopropyl)-carbo
diimide hydrochloride (EDC) and N-hydroxy-succinimide (NHS)
were purchased from Sigma-Aldrich Co. Ltd. UK. Dulbecco Modi-
fied Eagles Medium (DMEM), phosphate buffered saline (PBS), Foe-
tal Calf Serum (FCS), penicillin and streptomycin were purchased
from Invitrogen Life Sciences (UK). Other commercially available
reagents were all analytical grade.
2.1.3. Synthesis of GFOGER and GLOGEN peptides
Peptides were synthesized using method described in [22,35].
Briefly, we used an Fmoc/tert-butyl solid phase strategy on a Lib-
erty BlueTM microwave peptide synthesizer (CEM) on a 0.1 mmol
scale, using HCTU as coupling reagent and DIEA as base. Peptides
were assembled on Fmoc-Rink amide aminomethyl Tantagel resin
(0.526 g, loading 0.19 mmol.g1, RAPP Polymere) to yield C-
terminal amides. Fmoc removal was performed with piperidine
in DMF (20% v/v). Successive amino acid couplings and deprotec-
tion steps were carried out in DMF under microwave radiation.
After peptide assembly, resin beads were washed with dichloro-
methane (DCM) twice, methanol (MeOH) twice and DCM. Cleavage
from the resin was performed over 2 h in 10 ml of a mixture of
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v/v with 250 mg of dithiothreitol (DTT). The cleavage solution was
concentrated and precipitated in 20 ml of cold diethyl ether. The
white precipitate was filtered, washed with 10 ml of cold diethyl
ether twice and redissolved in a H2O/acetonitrile (ACN) 95/5 v/v
(0.1% TFA) mixture. The crude product was recovered after
freeze-drying and purified by preparative reverse-phase high per-
formance liquid chromatography (RP-HPLC) on a Perkin Elmer
LC200 system equipped with a 10 lm Eurospher II 100-10 C18 H
(Knauer, Berlin, Germany) with a linear gradient of ACN 0.1% TFA
in water 0.1% TFA. Purified compounds were characterized by
matrix-assisted laser desorption ionization time-of-flight
(MALDI-TOF) mass spectrometry at the Protein and Nucleic Chem-
istry Facility (University of Cambridge, Cambridge, UK). Full
sequence of GFOGER and GLOGEN peptides are GPC(GPP)5-
GFOGER(GPP)5GPC and GPC(GPP)5GLOGEN(GPP)5GPC, respec-
tively. The control triple-helical collagen-like peptide GPP10
(complete sequence, GPC(GPP)10GPC) was synthesized as
described previously [19,22].
2.1.4. Toolkit II-28 and III-7peptides
Toolkit peptides II-28 (GPC(GPP)5-
GEAGAOGLVGPRGERGFOGERGSOGAQ(GPP)5GPC) and III-7 (GPC
(GPP)5GETGAOGLKGENGLOGENGAOGPMGPR(GPP)5GPC were pro-
duced using the method described in [22].
2.2. Tested substrates
2.2.1. Monolayer coated surfaces
Collagens and peptides coatings were produced on the surface
of Immulon 2HB 96-well plates (Thermo Scientific) by incubating
100 ml/well of 10 mg/ml solution or suspension (for insoluble colla-
gen type I) in 10 mM acetic acid containing the appropriate pro-
teins/peptides over night at 4 C. Bovine serum albumin (BSA,
Sigma) and triple-helical-like sequences GPP10 were plated in trip-
licate to act as nonspecific background adhesion controls.
2.2.2. Films
First, slurries of insoluble collagen type I (derived from bovine
tendon Col (S) or skin Col(D)) were produced by swelling at 0.5%
(w/v) in 50 mM acetic acid at 4 C overnight and then homogenis-
ing on ice for 30 min at 13500 rpm using an Ultra-Turrax VD125
(VWR International Ltd., UK). Air bubbles were removed from slur-
ries by centrifuging at 2500 rpm for 5 min (Hermle Z300,
Labortechnik, Germany). Collagen films of 8 mm thickness were
prepared by pipetting 100 lL/well of these slurries directly in
Immulon 2HB plates (Thermo Scientific) and drying for 48 h in a
laminar flow cabinet.
Films were cross-linked (XL) with carbodiimide (EDC) in combi-
nation with succinimide (NHS). An EDC concentration of 11.5 mg/
ml, with a molar ratio of EDC/NHS/COO-(Col) = 5/2/1 in 95% (v/v)
ethanol, was taken as standard (100%) and was varied from 1 to
200%. These crosslinking conditions were selected on the basis of
our previous work where the effect of the reducing of standard
crosslinking concentration down to very low levels (up to 1%
EDC) on different relevant material and some cell-interactive prop-
erties was elucidated [24,32]. After reaction for 2 h at room tem-
perature, the films were washed thoroughly in deionised water
(15 min  5) and dried in a laminar flow cabinet.
2.3. Cell adhesion and spreading
Cell adhesion in the presence of Mg2+ (integrin-mediated) and
EDTA (non-divalent cation specific) was assessed by colorimetric
assay using a cytotoxicity detection kit (LDH), Roche, Cat. No 11
644 793001. This assay is based on the measurement of lactatedehydrogenase (LDH) activity release from lysed cells into the
media.
2.3.1. Cells adhesion on surfaces and films
All cell lines were maintained in a humidified incubator with 5%
CO2 at 37 C in DMEM, containing 10% fetal bovine serum and 1%
streptavidin/penicillin. Prior to cell adhesion experiments, cells
were detached from the cell culture flasks with 0.05% trypsin/0.02%
EDTA (GE Healthcare), washed and re-suspended in serum free
DMEM.
Before cell addition, non-specific adsorption to the coatings/-
films was blocked with 200 ll of bovine serum albumin (BSA, 5%
(w/v) in PBS) for 60 min, and then wells were washed three times
with 200 ll of PBS. 100 ll of cell suspension at different concentra-
tions (from 0.5 to 4  105 cells/ml in serum free DMEM) containing
either 5 mM MgCl2 or 5 mM EDTA, were added to wells and
allowed to attach at room temperature for 60 min. The wells were
thoroughly washed with PBS (200 ll 3) to remove loosely bound
cells and then 50 ll of lysis buffer containing 2% v/v Triton X-100
in distilled water was added for 90 min at room temperature. Sub-
sequently, 50 ll of LDH detection substrate (cytotoxicity detection
kit (LDH), Roche, Cat. No 11 644 793001), prepared according to
the manufacturer’s instructions, was added and left until color
had sufficiently developed as to be accurately detected (typically
from 10 to 30 min depending on the tested system). The variation
in time point influences the absolute absorbance value but does
not affect the adhesion profiles. The absorbance was read at 490
nm (A490) using a Fluostar Optima plate reader (BMG Labtech).
Background adhesion was determined on BSA and GPP10 coated
plates. Cell adhesion assays were performed in triplicate and val-
ues are reported as means ± standard deviations.
For quantitative analysis calibration curves, OD (optical density)
vs known cell concentration, were obtained for each experiment.
These were constructed by taking 500 ml of cell suspension at a
known cell density and subsequently diluting 32 to 64 times. Cells
were separated by centrifuging, lysed by adding of 250 ll of buffer
containing 2% v/v Triton X-100 in distilled water for 90 min at
room temperature, vortexed and then 50 ml aliquots of each solu-
tion were pipetted by triplicate in the same well plate in which
the corresponding cell attachment test was conducted. After that
50 ll of LDH detection substrate were added to the calibration ser-
ies at the same time as to the coated wells and left until color had
developed (from 10 to 30 min). The absorbance of this series was
read under the same conditions/time as on coated wells. A linear
regression was fitted to the known cell values, which was used
to calculate the cell number in the experimental wells. The selec-
tion of the time point for absorbance reading (color development)
has no impact on the percentage of adhesion calculated using cal-
ibration curves due to the same level of color development on cal-
ibration solutions and on tested wells.
2.3.2. Cell spreading tests
For spreading analysis, 100 ll of cell suspension at 1  105
cells/ml containing either 5 mMMg2+ or 5 mM EDTA in serum free
DMEM was added to BSA blocked surfaces for 90 min at 37 C/5%
CO2. The cells were fixed by the addition of 9 ll of 37% (w/v)
formaldehyde (final concentration 3.7%) directly to the cell media
for 20 min at room temperature. The samples were washed with
3  200 ll PBS then viewed using a LEICA DMI6000CS phase con-
trast microscope fitted with a LEICA DFC340FX camera. Cell
spreading (percentage of spread cells versus total number of cells)
was determined by analyzing 12 images per condition. A cell was
scored as spread if it was phase-dark with cellular projections
and a flattened morphology. Cells were scored as non-spread if
rounded and phase-bright with no cellular projections as detailed
in [18,36]. The percentage cell spreading was calculated by divid-
92 N. Davidenko et al. / Acta Biomaterialia 65 (2018) 88–101ing the number of spread cells by the total number of cells present.
Values are means of triplicate or quadruplicate measurements ± s
tandard deviation.
2.4. Integrin I domain binding analysis
Prior to I domain binding, coated plates were blocked with 5%
(w/v) BSA in binding buffer tris-buffered saline (TBS) (50 mM TRIS,
140 mM NaCl, pH 7.4, containing 1 mg/mL BSA) for 1 h at room
temperature. Following BSA blocking, the samples were washed
with 3  200 lL of binding buffer then incubated in 10 lg/mL of
the corresponding recombinant integrin a1 (human or rat) or a2
(human) I domain in binding buffer containing either 5 mM MgCl2
or 5 mM EDTA. After 1 h incubation at room temperature, the sam-
ples were washed in 3  200 lL of binding buffer containing 5 mM
MgCl2 or 5 mM EDTA respectively. The presence of the GST tagged
recombinant I domain was detected by incubating with 100 lL of
1:10,000 diluted HRP conjugate, Amershan GE Healthcare
RPN1236, for 1 h at room temperature. The detection antibody
was removed and the films were washed with 5  200 lL of bind-
ing buffer for each wash. 100 lL of TMB substrate (Thermo Scien-
tific) was added to each well and the reaction was stopped by the
addition of 100 lL of 2.5 M H2SO4 to each well. A450 was measured
using a Spectra Max 190 (Molecular Devices). Values are means of
triplicate or quadruplicate measurements ± standard deviation.
2.5. Statistical analysis
Unless otherwise stated all error bars indicate standard devia-
tions. Statistical significance was determined with a student t-
test with unequal variance where N/S indicates none statistically
significant (p > .05), ⁄indicates p  .05, ⁄⁄indicates p  0.01, ⁄⁄⁄indi-
cates p  .001 and ⁄⁄⁄⁄indicates p  0.0001. All statistical annota-
tions in films indicate the statistical difference between the data
point annotated and the 0% crosslinking values.3. Results
3.1. Cell adhesion and spreading on collagen coatings and peptides
Cell adhesion on coatings was carried out alongside synthetic
(GFOGER and GLOGEN) and Toolkit, II-28 and III-7, peptides (1)
to evaluate their affinity towards different integrins and (2) to con-
firm the activity of transfected cells. Short synthetic peptides pos-
sess one cell recognition ligand (GFOGER or GLOGEN) flanked by
five GPP sequences and one GPC triplet on both the N and C termi-
nal sides, which promotes a triple-helical configuration and
ensures their attachment to the plastic well surface. The selection
of these peptides was based on literature reports showing that
Toolkit II-28 peptide and its derivative GFOGER are high affinity
ligands for integrins a2b1 and a11b1 [19,37] while peptides III-7
and the corresponding GLOGEN were good ligands for a1b1 and
a10b1 [20,22]. An inactive peptide containing only the flanking
sequences GPP10 (GPC(GPP)10GPC) was used as a negative control
in this study.
Magnesium-dependent and non-specific, cation-independent
(EDTA) adhesion profiles for C2C12 cell line transfected with
human a1+, -a2+, -a10+ or a11+ integrins on different Col coatings
and peptides are presented in Fig. 2. It can be observed that all
adhesion is Mg2+-dependent, and so integrin-mediated for all inte-
grin transfected C2C12 cells. Original non-transfected C2C12 par-
ent cells, which do not endogenously express collagen-
recognition receptors, do not adhere to any substrate (data not
shown). The ligation properties to Col I (S, D) for a2 and a11–pos-
itive C2C12 follow the affinity Col I > Col II > Col III (Fig. 2B and D).For C2C12-a1+ cells (Fig. 2A) there is a significant increase in adhe-
sion on Col III in comparison with Col I and especially Col II. The
level of adhesion of a10+ cells on Col II and Col III was similar
but lower than on Col I (Fig. 2C).
The adhesion profiles on synthetic triple-helical (GFOGER and
GLOGEN) and Toolkit peptides followed the published trends [7]
thereby confirming that all transfected C2C12 cells correctly
express the cloned integrin. Furthermore, very similar adhesion
levels were observed on the short GFOGER and GLOGEN and their
longer corresponding Toolkit peptides for all transfected cells. The
binding properties of C2C12 with a1+ and –a10+ integrins appear
most similar (Fig. 2A and C). This was distinct from the comparable
ligation characteristics of a2+ and -a11+cells (Fig. 2B and D). The
adhesion values on GFOGER and II-28 peptides were similar to
those observed on full length Col I molecules for C2C12-a1+, -a2
+ and a11+ transfected cells. C2C12-a1+ and -a10+ positive cells
showed the highest attachment properties to GLOGEN and III-7
peptides which were comparable to the level of adhesion found
on Col III, especially in the case of a1+ cells.
To test the activity of endogenously expressed rather than
transfected integrins, cell adhesion assays were also carried out
using model cell lines HT1080 (human fibrosarcoma) and Rugli
(rat glioma). These each express a single, specific collagen-
binding integrin; as a2b1 and a1b1, respectively. Fig. 3 shows typ-
ical adhesion profiles for Rugli and HT1080 cells (Fig. 3B and D)
together with those found for C2C12-a1+ and C2C12-a2+ cell lines
at the same cell count (Fig. 3A and C). Col IV was included as it is a
known specific marker for cells expressing a1b1 integrin.
Comparison of adhesion results for C2C12-a1+ and Rugli, a1b1,
(Fig. 3A and B) showed that although both cell lines (with human
and rat a1b1 integrin, respectively) exhibited similar adhesion
trends (Col IV > Col III > Col I > Col II), the level of adhesion on
Col I and, especially on GFOGER, was significantly lower for Rugli
than for C2C12-a1+. This may be due to different expression levels
or could suggest differences in affinities of human and rat a1
receptors to different triple-helical peptides present on Col I. For
the human cell line expressing a2b1 integrin (HT1080) and mouse
myoblasts C2C12 with human -a2+, the adhesion patterns were
the same: Col I > Col II > Col III > Col IV.
Cell adhesion studies were carried out for different cell seeding
densities to assess the possible influence of this parameter on
adhesion profiles. It was found that for all transfected C2C12 cells
(with all Col-binding integrins) the level of cell binding was greater
on Col I(S) than on Col I(D) at lower cell counts (below 1.5  105
cells/ml). This effect can be seen in Fig. 3A and C for C2C12-a1
and a2 positive cells where adhesion values on Col I(S) are higher
than on Col I(D) for cell count 1  105 cells/ml. At cell densities
higher than 1.5–2  105 cells/ml, similar adhesion values were
observed on both dermal and tendon collagens. HT1080 and Rugli
cells were not sensitive to the collagen I source as the level of
attachment was the same on Col I(S) and Col I(D) at any cell den-
sity studied (examples are given in Fig. 3B and D).
Adhesion dependence on the cell seeding density showed that
Mg2+-dependent adhesion linearly increased with the initial cell
concentration in a range from 0.5 to 2  105 cells/ml but at higher
values this linearity was lost reaching saturation at cell densities
above 3-4  105 cells/ml (Fig. 4). Adhesion percentages calculated
from calibration curves using a cell density within the detection
range are presented in Table 1. These results show that the adhe-
sion percentage on Col I (S and D) coatings is higher for cells
expressing integrins a2 (HT1080 and C2C2-a2+) than for cells with
integrin a1. Col III and Col IV samples were more adhesive for cells
with a1 integrin in comparison with a2 receptor. This data also
highlight the differences in ligation properties between human
a1 and rat a1 integrins: for example the adhesion percentages of
C2C12-a1+cells on Col I (S and D) were noticeably higher than
Fig. 2. A representative data set showing the adhesion (optical density at 490 nm) profiles on Col coatings and peptides (n = 3 for each condition). Cell concentration 1.5 
105 cells/ml A–D adhesion of C2C12 cell line transfected with human a1+, -a2+, -a10+ and a11+ integrins, respectively. Statistical significance is shown compared to Col I(S)
for all collagen types and to GFOGER for all peptides.
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percentages (showed in Table 1) seem quite low which may be a
consequence of the experimental conditions chosen for the cell
adhesion assays: at room temperature, for relatively short dura-
tions, without CO2 supply, and using a stringent washing regime
to eliminate all loosely-bound cells. The level of adhesion will also
reflect the level of receptor expression, not quantified here. As a
result, these adhesion levels represent physiologically relevant
cation-dependent integrin-mediated anchorage of the selected cell
lines to the collagen substrates. This level of adhesion agrees well
with our previous reports, e.g. [18].
Cellular spreading assays were performed on fibrillar collagen
coatings using HT1080, Rugli and C2C12-a2 positive cells. C2C12
original non-transfected mother cells were employed as a negative
control. The aim of this study was to determine whether the cell
adhesion noted earlier leads to cell spreading as a result of the cor-
rect stimulation of certain signaling pathways after attachment.
These assays were conducted in the presence of Mg2+ as no cell
spreading was observed in the presence of EDTA (data not shown).
It should be mentioned that these tests were carried out in theabsence of serum in the cell media to prevent cell adhesion to
serum containing proteins such as vitronectin and fibronectin that
can bridge between Col and cells. Images showing the cell shape in
the presence of Mg2+ for HT1080, Rugli, transfected C2C12-a2+ and
‘‘blank” C2C12 are displayed in Fig. 5A. It can be observed that all
cell lines with collagen-binding integrins (HT1080, Rugli and
C2C12-a2+) are similarly spread on all Col coatings: almost all
attached cells look flattened with a phase dark appearance. Spread-
ing quantification (Fig. 5B) showed a high degree of cell spreading
(between 95 and 85%) for all Col-based surfaces. Non-transfected
C2C12 cells were not spread on any collagen samples; in the case
of Col I coatings, where some attachment was observed, all cells
were phase bright and rounded.
3.2. Cell adhesion on Col I films
Fibrillar collagen I samples used in films and in coatings were
analyzed for their amino acid content (as described in our previous
works [17,29]). Equivalent total protein content was observed in
the as-received collagen preparations of insoluble Sigma and Devro
Fig. 3. Representative profiles of C2C12-a1+ (A), Rugli (B), C2C12-a2+ (C) and HT1080 (D) cells at cell count 1  105 cells/ml. Statistical significance is shown compared to Col
I(S) for all collagen types and to GFOGER for all peptides.
Fig. 4. Examples of adhesion dependence on initial cell concentration for Col I
samples.
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(S.D. n = 4), respectively. Films produced from these collagens were
EDC cross-linked to establish the effect of collagen origin and the
influence of variations in crosslinking conditions on cell behaviour
on 2D samples. The same method for film preparation was used for
both Col I samples. It was developed, validated (in term of collagenalignment, the surface structure, covering quality, thickness, etc.)
and reported in our previous works [29]. For example, it was
showed that the employed method provided films with the aligned
fibre bundles of collagen within the plane of the films, homoge-
neously covering the underlying surface with similar topographic
characteristics and thickness (in the range of 7–10 mm) for both
non-treated and crosslinked samples. It was also demonstrated
that EDC crosslinking did not induce any non-uniform changes in
film morphology or protein distribution. Fig. 6 shows the adhesion
profiles of C2C12 non-transfected mother cells (Fig. 6A) and C2C12
myoblasts transfected with all collagen-recognition integrins
(Fig. 6B–E) on Col(S) and Col(D) films crosslinked with different
concentration of EDC (from 0 to 200%). No adhesion of C2C12
‘‘blank” cells was detected on any film. This was expected as this
cell line does not express any collagen-binding integrin (Fig. 6A).
All adhesion of transfected C2C12 cells was Mg2+-dependent
(Fig. 6B–E) and the profiles share similarity in their dependence
on EDC crosslinking dose: adhesion decreases with increasing
EDC crosslinking. It can be observed that collagen origin influences
the degree of adhesion, which, in addition, was sensitive to the
integrin class involved in cell-substrate ligation. For example
C2C12-a2 cells adhered similarly to both dermal and tendon Col
samples (Fig. 6B) at all crosslinking concentrations. Conversely,
for the other transfected cells (C2C12-a1, -a10 and -a11+)
Table 1
Percentage of cell adhesion expressing Col-binding integrins on different Col surfaces.
Col Type HT1080 (a2b1) C2C12-a2 Rugli (a1b1) C2C12-a1
Adhesion (%) for cell count 1  105 cells/ml
Col I (S) 45.6 ± 6.4 44.2 ± 2.2 22.8 ± 2.7 36.4 ± 2.9
Col I (D) 43.6 ± 3.0 36.5 ± 0.5 27.0 ± 4.1 34.8 ± 2.7
Col II 40.3 ± 1.3 23.9 ± 3.0 18.9 ± 2.6 23.4 ± 1.5
Col III 28.1 ± 1.6 18.5 ± 0.5 55.6 ± 5.5 44.2 ± 2.5
Col IV 24.7 ± 2.0 16.1 ± 0.5 64.1 ± 6.4 51.9 ± 3.2
Fig. 5. Images of cell spreading (A) of HT1080, Rugli, C2C12 and C2C12-a2+ cells and spreading percentage (B) on collagen surfaces. Scale bar is 100 mm.
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parison with tendon, Col(S), at all XL conditions except 100 and
200% where no cell binding was observed (Fig. 6C–E). Adhesionpatterns were similar for -a2+ and a11+positive cells: collagen
ligation was not affected with up to 10% EDC crosslinking
(Fig. 6B and E). By contrast a1+ and a10+ C2C12 cell attachment
Fig. 6. Adhesion profiles of C2C12 cells (A), C2C12 transfected with human -a2+(B), a1+(C),-a10+(D) and -a11+(E) integrins on Col-I films with different crosslinked status.
Initial cell concentration: 3  105 cells/ml. Statistical significances compared to 0% XL Col samples are shown above the data points. Statistical differences between Col I(S)
and Col I(D) for the same crosslinking condition are shown below the ‘‘X” axis. For C2C12 and C2C12-a2 cells there are no significant differences between the adhesion values
on Col I(S) and Col I(D) films with the same crosslinking conditions.
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centrations (1% and 3% for Col (D) and Col (S), respectively,
Fig. 6C and D).
The adhesion of human fibroblasts HT1080 (a2b1) and rat
glioma Rugli cells (a1b1) to Col I films with different crosslinking
states was also tested (Fig. 7). For each cell line, the adhesionFig. 7. Adhesion profile of HT1080 (A) and Rugli (B) cells on Col-I films with different c
compared to 0% XL Col I(S) is shown above each data point. There are no significant dif
crosslinking conditions.profiles were not dependent on Col origin as adhesion values on
Col(S) and Col((D) were very similar for all crosslinking conditions
used. However, the sensitivity of HT1080 and Rugli attachment to
EDC crosslinking was very different. HT1080 (a2b1) attachment
started to decrease from 10% EDC concentration onwards, showing
the same profiles to those found for C2C12-a2+ (Fig. 6B). However,rosslinked status. Initial cell concentration: 3  105 cells/ml. Statistical significance
ferences between the adhesion values on Col I(S) and Col I(D) films with the same
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observed on both dermal and tendon Col films after crosslinking
treatment with only 1% of EDC (Fig. 7B). This pattern is signifi-
cantly different to that observed for C2C12-a1+ cells (Fig. 6C) sug-
gesting different response of cells transfected with human
compared to endogenous rat a1-integrins.3.3. Attachment of -a1 human I-domain and -a1-rat I domain on
different collagens and selected synthetic and Toolkit peptides
Attachment tests were carried out using purified recombinant I
domains derived from a1-subunits of human and rat integrins. The
aim of this study was to understand whether differences found in
the interactive properties of cells expressing human a1- (C2C12-
a1+) and rat a1- (Rugli) receptors with collagen substrates were
due to (1) different expression levels on the corresponding cell sur-
faces or (2) due to differences in affinities of a1-human and a1-rat
receptors towards collagen binding ligands. Additionally, this anal-
ysis could shed light on the different response of cells with human
and rat a1 integrins to EDC crosslinked films. ELISA-based detec-
tion of I-domains bound to the selected synthetic and Toolkit pep-
tides (Fig. 8A–C) and to different collagen types (Fig. 8D) showed
significant differences in the adhesive properties between human
and rat a1 I domains. Human integrin a1 I domain ligates to a
greater variety of collagen derived triple-helical ligands, although
GLOGEN sequences (GLOGEN peptide and Toolkit III-7) show the
greater affinity. By contrast rat a1 I domain shows affinity
only to the GLOGEN motif and to Toolkit III-7 which contain theFig. 8. Attachment of a1 I domain (human and rat) on different collagens and selected s
Toolkit and synthetic peptides. EDTA controls block all binding to peptides (data not show
EDTA; C – rat a1 vs human a1 and a2 I-domains binding to GFOGER; D – human vs ratGLOGEN ligand (Fig. 8A, B). Human a1 I domain ligation to GFOGER
peptide and GFOGER-containing II-28 was very high and compara-
ble with the level of adhesion found for the human a2 I domain.
Human a2-GFOGER interactions are considered high affinity [7],
therefore this human a2 control was included to allow direct com-
parison showing that human a1, but not rat a1, has a similar affin-
ity to GFOGER as human a2 I domain (Fig. 8A and C). In contrast,
almost no adhesion was detected for rat a1 I domain on GFOGER
and on II-28 where the absorbance signal was near to the back-
ground level and to that in the presence of EDTA,
Fig. 8A, B and C. Integrin a1 human I domain and rat a1 I domain
show different affinities of ligation to different collagen types
(Fig. 8D). The binding of human a1 I domain on Col I, II and III
was considerably greater than that of the rat a1 I domain to the
same collagen samples (Fig. 8D). However, the level of adhesion
on Col IV was similar for both human and rat a1 I domains.4. Discussion
4.1. Adhesion and spreading on coatings
Monolayer coatings allow the detection of integrin recognition
sequences in collagen substrates by evaluating the affinity and
availability of their biological cues towards variety of cellular
receptors. These coatings were prepared from diluted (well below
their saturation limits), highly homogenised solutions/suspensions
of the corresponding collagen substrates. By using an appropriate
coating concentration, this assessment is independent of theynthetic and Toolkit peptides: A – rat and human a1 I-domains binding to selected
n); B – a 1 I-domain binding to GFOGER, GLOGEN and II-28 in presence of Mg 2+ and
a 1 I-domains binding to different collagens.
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deposited onto the solid cell culture plastic, so creating a surface-
bound assembly of integrin recognition sequences typical to each
collagen type. Three fibrillar collagens (types I, II and III) and the
network Col IV, known as a selective ligand for a1b1 integrin [7],
were chosen for this study to examine the cell-recognition
sequences that support integrin ligation [6,7]. As these collagens
possess different solubility, the effect of this parameter on their
surface immobilization was investigated. Enzyme linked
immunosorbent assays (see supplementary data on collagen detec-
tion) show identical detection of collagen on coatings derived from
insoluble Col I suspensions or a soluble Col I solution. This demon-
strates that when incubated at excess, the solubility of the starting
materials does not play an important role in the total surface cov-
erage, which, in turn, provides the basis for comparing the
response of cells expressing defined receptors to the different col-
lagens. Through this analysis, the importance of the structural and
sequence diversity on their interaction with integrin receptors was
determined. In our previous work, we have shown that macro-
molecular triple-helical structures of Col I may display differences
in their fiber architecture (fiber lengths, width, entanglement),
when derived from different tissues (dermal and tendon). In turn,
these structural modifications induce changes in the material
properties of 3D scaffolds produced from these precursors [24].
Here, we extend upon this to determine whether these changes
also impact on the biological function of this protein. C2C12 cells
transfected independently with each of the four collagen-binding
integrins showed that at low cell counts (within the linear concen-
tration dependent zone) tendon collagen seems to be more cell-
adhesive than its dermal equivalent. This may be a consequence
of differences in the exposure of cell-adhesion sequences in these
samples. Furthermore, as these collagen preparations possess dif-
ferent physical properties such as fibre diameter and stiffness,
the differential cell adhesion could be due to surface-induced con-
formational and/or orientation changes, as observed previously for
gelatin-coated surfaces [18].
The differential cell binding to collagen type I, II, III and IV may
be accredited to the differences in the specific GxOGEx’ motifs and
their corresponding affinities towards different Col-binding inte-
grins. The distribution of GxOGEx’ sequences across fibrillar colla-
gens have been previously identified (Table 2) [7] by using
homotrimeric collagen-derived triple-helical peptide libraries
called Toolkits. These assays also established that the affinity order
in GxOGER ligands towards a2b1 integrin ligation showed the
trend where was x = F > L  R > M > A [7], indicating that GFOGER
(found in Col I and Col II) is the highest affinity ligand for this
receptor. Our results agree with relative affinities. We observed
the highest adhesion values of C2C12-a2+ and HT1080 cells, both
expressing a2b1 integrin, on Col I/Col II coatings and on GFO-
GER/Toolkit II-28 peptides (Fig. 2 and 3C and D and Table 1).
C2C12-a11+ myocytes showed very similar binding properties toTable 2



















Collagen II GFOGER, GLOGER, GMOGER
Collagen III GROGER, GMOGER, GAOGER,
GLOGENa2-positive cells on collagen monolayers, which followed the trend
Col I > Col II > Col III, and on collagen Toolkit peptides
(Figs. 2 and 3C and D). This suggests that GFOGER is a high affinity
ligand for integrin a11. A high level of C2C12-a1+ and Rugli (a1b1)
cell adhesion on Col III/IV and GLOGEN/Toolkit III-7 peptides is
consistent with the presence of the GLOGEN motif within all of
these substrates, as this motif has been identified as a high affinity
sequence for integrin a1b1 [7,22]. Col IV promoted high levels of
adhesion for cells containing integrin a1 (Fig. 3A, B) which agrees
with the definition of this network collagen as a selective ligand for
a1b1 integrins [7]. It has also been reported that the affinity of
GLOGEN for integrin a1b1 is comparable with that of GFOGER [7]
which is in accordance with the high attachment levels to Col I
and GFOGER/II-28 peptides we observed on C2C12 transfected
with human integrin a1 (Figs. 2 and 3A). Conversely Rugli cells,
expressing rat integrin a1, showed very low adhesion levels on
GFOGER which may explain the low attachment to Col I and Col
II as these contain GFOGER as their primary cell-binding motif
(Fig. 3B). Differences in the cellular response of Rugli and C2C12-
a1+cells cannot be attributed to differences in the receptor density
on the cell surface as both cell lines show very similar integrin-
dependent adhesion to Col IV and on Toolkit III-7 peptides. Instead
this points to different affinities between rat and human integrin
a1 towards certain cell recognition sequences such as GFOGER.
Therefore this suggests that not only integrin class, but also the
species-specificity, may affect collagen-receptor interactions. Thus
we highlight the importance of using humanised test systems for
cell adhesion analysis.
The binding properties of C2C12 a1+ and a10+ were very sim-
ilar (Fig. 2) except for on Col III where C2C12-a1+ cells showed
greater attachment than a10+ cells. This may suggest that either
Col III contains auxiliary motifs alongside GLOGEN, which possess
different affinities towards integrins a1 and a10, or alternatively
that there are differences in the display of GLOGEN sequences on
Col III towards a1 and a10 receptors.
The similar adhesion levels observed on short synthetic pep-
tides and their longer Toolkit equivalents seem in contradiction
with the predicted density of cell recognition sequences due to
the different masses of these peptides. Each peptide contained a
single active collagen-recognition motif (GFOFER or GLOGEN);
however the shorter peptides contain 42 amino acids (AA) whilst
the larger Toolkit counterparts are considerably longer (63AA). As
a consistent mass of peptide was applied to the tissue culture plate
surface, this implies that the active ligand density of the short pep-
tide might be 50% higher that of the longer Toolkit peptide, assum-
ing uniform monolayer coating. However, this apparent difference
in density does not invoke a corresponding increase in cell adhe-
sion. This may be due to a number of reasons. Firstly, it is possible
that cell binding is saturating on the longer peptide and so the
higher density of the shorter peptide cannot elicit a further effect.
Secondly, it could be that the larger, native-derived Toolkit pep-
tides have a higher affinity for cell integrins in comparison to the
shorter sequences due to differences in flexibility and in conforma-
tion of their triple-helical structures. There are differences in tran-
sition temperatures (Tm) between short peptides and Toolkit
peptides. The Tm of GFOGER is almost 10 C higher than that of
Toolkit peptides: Tm of GFOGER = 56 C [35] and Tm of II-28 and
III-7 were 46 C and 45 C, respectively (data not published). It is
possible that this reflects a tighter, more compact triple-helical
configuration of GFOGER than the longer Toolkit peptides. Native
collagen approximates to 10-fold axial symmetry, whereas the
GPP-containing flanking sequences adopt 7-fold symmetry. The
transition between the two is not abrupt [13,15], so that the helical
twist of the GFOGER motif differs slightly depending on its local
setting, and may influence the position and exposure of its amino
acid residues (especially E) to integrins. It is also possible that
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conformation upon surface immobilisation resulting in greater
activity towards cell receptors. Finally, the Toolkit peptides include
primary sequence on each side of the active motif which may con-
tribute to better recognition by native integrins. In accord with this
theory, in the case of Rugli cells, with rat integrin a1, lower adhe-
sion levels on shorter in comparison to the corresponding longer
Toolkit peptides was noted. It is possible that the rat integrin a1
is more sensitive to the collagen conformation, indicating that a
native-like structure of adhesion motifs is critical for their activity.
This is consistent with numerous reports showing that cell adhe-
sion to GxOGEx’ motifs is dependent upon a triple-helical confor-
mation. This theory may explain, to some extent, the similar
level of adhesion found on complete collagen molecules compared
with the corresponding peptides which, due to their differential
mass, would possess different surface densities (almost 15–25
times higher on peptides than on full collagen molecules). It is also
likely that adsorption efficiency to the well surface of large colla-
gen molecules differs from the comparatively short synthetic and
Toolkit peptides which may affect the exposure of their cell-
adhesive motifs. To finish, it is plausible that changes in the topol-
ogy between the intact collagen molecules and peptides coatings,
for example large fibrils on fibrillar collagens vs small structures
on both types of peptides, may result in altered integrin ligation.
Cellular spreading analysis was performed to determine
whether cation-dependent integrin-mediated cell adhesion could
elicit flattened native-like cell morphology. Spreading of HT1080,
Rugli and C2C12-a2+ cells, all expressing collagen-binding recep-
tors, was high on all Col-based surfaces. This indicates that these
substrates are capable of stimulating cell-signalling mechanisms
that lead to spreading. As such it appears that integrin-mediated
cell engagement with collagen can induce cell spreading via both
integrin a2 and a1. Moreover this is not sensitive to the human
or rat cell origin, showing that they interact with collagen sub-
strates in a physiologically relevant manner leading to a very sim-
ilar level of spreading that is independent on the collagen type and
tissue source.
4.2. Adhesion on films
Adhesion tests were carried out on 2-dimensional films
obtained from insoluble tendon and skin derived Col I and cross-
linked with different doses of EDC. As Col I continue to be a pre-
dominant choice for the design of protein-based biomaterials the
understanding of its adhesive characteristics, when derived from
different tissues, and analysed with a diversity of cellular models,
as presented here, may assist in the selection of optimum struc-
tural components for collagen-based cell supports.
EDC crosslinking is one of the most effective treatments for
improved structural stability, resistance to dissolution and tailored
mechanics of collagenous matrices with implications for their clin-
ical use as tissue engineering biomaterials. As EDC-mediated bond-
ing impacts on cell-substrate interactive properties it is important
to balance the need for structural integrity and mechanics against
bioactivity in each specific clinical case. In our previous works we
investigated the effect of reducing the EDC concentration down to
very low levels (up to 100 times dilution, 1% EDC, with respect to
standard condition) on the physical and cell-interactive properties.
We demonstrated, for example, that the EDC/NHS crosslinking
dose influences both the level and the mode of cellular engage-
ment to tendon-derived Col [32]. Cell attachment changed from
predominantly integrin-mediated in the absence of EDC treatment,
to divalent cation-independent with high EDC crosslinking concen-
trations (between 100 and 500%). In this work, we further assess
the influence of EDC crosslinking on the ligation of cells with sin-
gle, defined, integrin populations to collagen substrates. Therefore,we were interested in the effect that the collagen source induces
on cell adhesion and, additionally, if cell adhesion sites on dermal
and tendon-derived samples were equally altered by
carbodiimide-mediated bonding. In contrast with the earlier study
[32], here, through the use of specific experimental conditions, we
focused on only physiologically relevant cation-dependent
integrin-mediated anchorage of the four different collagen-
binding integrins to collagen substrates. In particular, we intro-
duced modifications to the cell adhesion methodology compared
with that employed in the cited work [32]. This involved limiting
the crosslinking concentration to 200% EDC (maintaining consis-
tent the dilution levels up to 1%) and conducting the cell adhesion
assay on the bench, at room temperature and without CO2. In addi-
tion, a more stringent washing regime was used to ensure the com-
plete removal of loosely-bound or non-Mg2+-dependently attached
cells from material surfaces. Through these modifications the non-
cation dependent adhesion was limited, allowing us to examine
only intimate, strong cell-substrate interactions. As such, this min-
imised lower affinity non-native-like collagen binding. Using this
experimental approach, our results showed that crosslinking
strongly decreases integrin-mediated cell binding of all cell lines
via all four collagen-binding integrins (a1b1,a2b1, a10b1 and
a11b1) to all films. The shape of the adhesion curves (A 490 nm
vs EDC %) for HT1080 and C2C12 transfected cells resemble that
found for the amine group content on Col (S) and Col (D) as a func-
tion of EDC concentration [24]. According to the well-established
crosslinking mechanism, the number of amine groups involved in
the EDC-promoted bonding is proportional to the quantity of car-
boxylic moieties on the AA residues (such as glutamate and/or
aspartate) participating in the linkage. These same carboxylic
groups are critical for cation-coordination between I domains of
integrins and collagen and so EDC crosslinking, by consuming
important chemical elements of the cell recognition sequences in
collagen, depletes cell attachment to highly crosslinked collagen.
These results are in agreement with our previous reports
[18,24,29] where we hypothesise that carbodiimide treatment of
collagenous materials significantly decreased the content of
important carboxylic groups on glutamate and aspartate amino
acid residues.
The adhesion of transfected C2C12 cells on films showed that
the collagen origin substantially influenced the adhesion profiles.
Comparison between the transfected lines showed that this adhe-
sive profile was sensitive to the class of integrin involved in cell-
substrate ligation. Contrary to the ligation levels observed on coat-
ings, the adhesion values for almost all receptors, with the excep-
tion of a2, were higher on dermal collagen films than on their
tendon-derived equivalents. This lower adhesion observed on der-
mal collagen monolayers could be attributed to a number of factors
including the surface protein density, differences in collagen
preparation from each source, or possible conformational changes
due to surface interaction. Our films were 8 mm thick, meaning
that the surface cell-recognition ligands are separated from the
underlying plastic by a large number of collagen molecules. As
such, it is highly unlikely that any surface-induced alteration of
the collagen structure would be propagated to the surface and so
influence the binding of cells to Col films. By contrast, on monolay-
ers, the plastic could influence the structure of collagen molecules
exposed to cells. Interestingly this higher adhesive level on Col I(D)
films was noted for a1+, a10+ and a11+ but not a2+ C2C12 cells.
As integrin a2 has a different affinity for cell-binding motifs in col-
lagen, this may point to differences in the number or display of cer-
tain triple-helical motifs on dermal versus tendon collagen. It is
also possible that bulk material properties may modulate, to some
extent, integrin engagement to the films but not the monolayers.
For example, we have found that the resistance to compression
of matrices obtained from tendon collagen is higher than that of
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ing differently to the mechanical environment in conjunction with
the specific integrin binding sequences involved. This is in accor-
dance with reports suggesting that integrins play a significant role
in propagating mechanical cues to cells even at an early stage of
cell-substrate interaction [1].
Differences were noted in the adhesion profiles of cells trans-
fected with different integrins as a function of EDC-dose. This
may point to differential sensitivity to EDC crosslinking of each
of the glutamate-containing GxOGEx’ cell binding motifs. Each
motif has a different integrin binding affinity, and so an unequal
alteration of these cell recognition motifs by EDC may, in turn, alter
the specific integrin binding profile of collagen I. EDC crosslinking
up to 10% EDC concentration did not lead to an appreciable
decrease in the adhesion of a2+ and a11+ positive C2C12 cells.
These lines bind predominantly to high affinity GFOGER motifs,
suggesting that the amount of unmodified GFOGER in low cross-
linked samples was still sufficient to maintain cell adhesion,
despite consumption of some glutamate (E) residues. Conversely,
the EDC-induced decrease in a1 and a10 mediated cell binding
to other GxOGER sequences, for example GLOGER, seems to be
more sensitive to crosslinking. This may explain the observed drop
in adhesion values for a1+ and a10+ cells even at low, 3% EDC con-
centrations. This effect is even more evident in Rugli cells with rat
integrin a1 than for human integrin a1 containing C2C12 cells sug-
gesting species-dependent affinity modulation of this receptor.4.3. Attachment of -a1 human I-domain and -a1-rat I domain
Integrins a1b1 and a2b1 bind to collagen via inserted I-
domains within the a-subunit (Fig. 1, [7]). Therefore, isolated
recombinant human and rat integrin a1 I domains were used to
assess integrin-collagen engagement in a cell-free system. The
results agreed with the differences found in the adhesion of cells
expressing human and rat integrin a1b1. They show that the dif-
ference in C2C12-a1+ and Rugli cell adhesion (with human and
rat a1 receptors, respectively) in response to the dose of EDC used
for collagen crosslinking was due to differential I domain binding.
The observed lack of rat integrin a1 I domain engagement with
GFOGER and with II-28 peptides (Fig. 8A and B) is consistent with
low adhesion of Rugli cells on Col I/II coatings and these peptides.
By contrast, C2C12 cells transfected with human a1 showed high
adhesion levels on the same coatings which agree with the high
affinity of human integrin a1 I-domain to GFOGER collagen
sequences. In general, we have showed that while human integrin
a1 I domain ligates to a wide variety of collagen derived triple-
helical ligands, rat I domain shows high specificity almost exclu-
sively to GLOGEN-containing sequences, that is synthetic GLOGEN
and its Toolkit equivalent III-7 (Fig. 7A). These motifs are not pre-
sent in Col I (see Table 2) and so rat integrin a1 binding to Col I is
dependent upon lower affinity motifs. Therefore even a small
decrease in the availability of these lower affinity sites, for example
through EDC crosslinking, may lead to the significant loss of colla-
gen binding capacity of cells expressing rat integrin a1. At the
same time, cells which contain the human a1 I domain bind to a
wider variety of similar triple-helical sequences including the GFO-
GER motif in Col I (Fig. 8A) and were much less sensitive to
crosslinking. Presumably this is due to the higher affinity of GFO-
GER for human but not rat integrin a1. Additionally the different
ligation behaviour of human and rat integrin a1 I domains may
also explain the considerably elevated adhesion of cells with
human a1 on Col I and II as this can occur through high affinity
GFOGER motifs. Together these results show that both the integrin
class and species-specificity dictate the affinity of these receptors
to cell recognition motifs in different members of collagen family.5. Conclusions
Integrins play a vital role in determining the cell response to
environmental cues during the early stage of cell-substrate interac-
tion. Therefore a detailed understanding of integrin binding to col-
lagens, as widely used in biomaterials fabrication, is pivotal for
endowing these materials with appropriate bioactivity. Here, we
found that the cellular response to both the collagen type and ori-
gin is highly dependent on the specific integrin type and species
being studied. This is due to integrin I domain interactions with
collagen as shown using recombinant human and rat integrin
a1-I domain binding assays. As for whole cell assays, these exhib-
ited receptor class and species specificities of collagen interactions.
Combining the results of cell attachment on differently crosslinked
collagen films with those obtained in integrin a1-I-domain bind-
ings studies, the biological response of human and rat cells (with
the same a 1 integrin) to changes in the collagen type and origin
and the EDC crosslinking status were elucidated. We have shown
that EDC treatment decreases the overall amount of cell recogni-
tion sequences, whilst simultaneously altering the adhesive ratio
among the different motifs on collagen molecules which further
affected the specific integrin class that ligates to these collagen
substrates after crosslinking. This comprehensive study of all four
of the collagen-binding integrins gives key guidance in selection
of the correct cellular model for the biological testing of biomate-
rials. For example we clearly show that rat models, which are used
extensively for biological studies, may give different results from
human-based systems. In summary, our data show that the colla-
gen precursor should be carefully chosen dependent on the cell
type to be incorporated and on the tissue to be replaced. This will
assist in the selection of optimal materials for the design of cellular
supports for different TE applications.Acknowledgements
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